Experic
Private Company
Total funding raised: $25M
Overview
Experic is a specialized CDMO focusing on the challenging niche of powder-based drug products, particularly for inhalation delivery. Its core expertise lies in process development, clinical and commercial manufacturing, and comprehensive clinical trial supply services including packaging, labeling, storage, and global logistics. With facilities in the US and EU, Experic is positioned to support global pharmaceutical and biotech clients through all stages of development, from clinical trials to commercialization. The company emphasizes a collaborative approach and technical proficiency in handling potent and low-dose APIs.
Technology Platform
Specialized expertise in powder science and engineering, with a focus on Dry Powder Inhalation (DPI) formulation, process development, and manufacturing for potent and low-dose APIs. Capabilities include tailored equipment design and comprehensive clinical trial packaging/storage systems.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Experic competes in a crowded CDMO market, differentiating itself as a specialist in powder handling and inhalation. It faces competition from large players like Lonza and Catalent, as well as focused inhalation experts like Hovione. Its success hinges on superior technical expertise and personalized service in its niche.